BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10364606)

  • 21. Parvovirus B19 infection in pregnancy.
    Eis-Hübinger AM; Dieck D; Schild R; Hansmann M; Schneweis KE
    Intervirology; 1998; 41(4-5):178-84. PubMed ID: 10213893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis of human parvovirus B19 infection in nonimmune hydrops fetalis].
    Lenkiewicz B; Roszkowski T; Grabarczyk P; Moraczewska Z; Brojer E; Zupańska B
    Ginekol Pol; 1998 Apr; 69(4):175-81. PubMed ID: 9640861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [PCR value in the diagnosis of feto-placental human parvovirus B19 hydrops fetalis: apropos of 10 cases].
    Wattré P; Thirion V; Bellagra N; Subtil D; Andreoletti L; Hober D; Lion G; Dewilde A
    Ann Biol Clin (Paris); 1997; 55(4):327-31. PubMed ID: 9309232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trisomy 21 and hydrops fetalis: parvovirus B19 or transient abnormal myelopoiesis?
    Tan LN; Cheung KW; Kilby MD
    J Obstet Gynaecol; 2019 May; 39(4):556-557. PubMed ID: 30634881
    [No Abstract]   [Full Text] [Related]  

  • 25. Intrauterine parvovirus B19 infection: early prenatal diagnosis is possible.
    Trotta M; Azzi A; Meli M; Borchi B; Periti E; Pontello V; Leoncini F
    Int J Infect Dis; 2004 Mar; 8(2):130-1. PubMed ID: 14732332
    [No Abstract]   [Full Text] [Related]  

  • 26. [Parvovirus B19 infection in pregnancy: a cause of non-immune hydrops fetalis].
    van Gessel PH; Wildschut HI; Cohen-Overbeek TE; Vermeij-Keers C
    Ned Tijdschr Geneeskd; 1999 Jan; 143(1):3-7. PubMed ID: 10086088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic and therapy of a severe fetal parvovirus-B19-infection with persistence of viral DNA in the mothers blood but inconspicuous serological tests. Case report].
    Stenner S; Enders G; Klee A; Eiden U; Weidner A; Gonser M
    Z Geburtshilfe Neonatol; 2002; 206(3):102-6. PubMed ID: 12098826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemiluminescence dot blot hybridization assay for detection of B19 parvovirus DNA in human sera.
    Musiani M; Zerbini M; Gibellini D; Gentilomi G; Venturoli S; Gallinella G; Ferri E; Girotti S
    J Clin Microbiol; 1991 Sep; 29(9):2047-50. PubMed ID: 1774333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency of parvovirus B19 infection in nonimmune hydrops fetalis and utility of three diagnostic methods.
    Essary LR; Vnencak-Jones CL; Manning SS; Olson SJ; Johnson JE
    Hum Pathol; 1998 Jul; 29(7):696-701. PubMed ID: 9670826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of parvovirus B19 in macerated fetal tissue using in situ hybridisation.
    Walters C; Powe DG; Padfield CJ; Fagan DG
    J Clin Pathol; 1997 Sep; 50(9):749-54. PubMed ID: 9389975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemiluminescent in situ hybridization for the detection of cytomegalovirus DNA.
    Musiani M; Roda A; Zerbini M; Pasini P; Gentilomi G; Gallinella G; Venturoli S
    Am J Pathol; 1996 Apr; 148(4):1105-12. PubMed ID: 8644853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of human parvovirus B19 DNA in maternal and fetal serum, and amniotic fluid during an early stage of pregnancy.
    Ishikawa A; Yoto Y; Asakura H; Tsutsumi H
    J Med Virol; 2015 Apr; 87(4):683-5. PubMed ID: 25611946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique.
    Török TJ; Wang QY; Gary GW; Yang CF; Finch TM; Anderson LJ
    Clin Infect Dis; 1992 Jan; 14(1):149-55. PubMed ID: 1571420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal hydrops secondary to human parvovirus infection in early pregnancy.
    Petrikovsky BM; Baker D; Schneider E
    Prenat Diagn; 1996 Apr; 16(4):342-4. PubMed ID: 8734809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-isotopic in situ hybridisation and immunophenotyping of infected cells in the investigation of human fetal parvovirus infection.
    Morey AL; Porter HJ; Keeling JW; Fleming KA
    J Clin Pathol; 1992 Aug; 45(8):673-8. PubMed ID: 1401175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of fetal hydrops and non-hydropic late intrauterine fetal death after gestational parvovirus B19 infection.
    Enders M; Klingel K; Weidner A; Baisch C; Kandolf R; Schalasta G; Enders G
    J Clin Virol; 2010 Nov; 49(3):163-8. PubMed ID: 20729141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis.
    Nunoue T; Kusuhara K; Hara T
    Pediatr Infect Dis J; 2002 Dec; 21(12):1133-6. PubMed ID: 12488663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Parvovirus-B19 infection in pregnancy: a cause of nonimmune hydrops fetalis].
    Knol A
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):541; author reply 542. PubMed ID: 10321268
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytodiagnosis of parvovirus B19 infection from ascites fluid of hydrops fetalis: report of a case.
    Iwa N; Yutani C
    Diagn Cytopathol; 1995 Aug; 13(2):139-41. PubMed ID: 8542793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-uterine parvovirus B19 infection and meconium peritonitis.
    Zerbini M; Gentilomi GA; Gallinella G; Morandi R; Calvi S; Guerra B; Musiani M
    Prenat Diagn; 1998 Jun; 18(6):599-606. PubMed ID: 9664606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.